William Iii Slikker

William Iii Slikker's AcademicInfluence.com Rankings

William Iii Slikker

Medical

#3014

World Rank

#3465

Historical Rank

Pharmacology

#350

World Rank

#401

Historical Rank

medical Degrees

Download Badge

Medical

William Iii Slikker's Degrees

PhD Pharmacology University of Arkansas for Medical Sciences
Masters Pharmacology University of Arkansas for Medical Sciences
Bachelors Pharmacy University of Arkansas for Medical Sciences

Why Is William Iii Slikker Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William Iii Slikker's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. (2006) (1135)
Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration (1997) (1009)
Ketamine-induced neuronal cell death in the perinatal rhesus monkey. (2007) (565)
Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. (2011) (508)
Further studies of the role of hyperthermia in methamphetamine neurotoxicity. (1994) (420)
Prevalence of Femoroacetabular Impingement Imaging Findings in Asymptomatic Volunteers: A Systematic Review. (2015) (352)
Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. (2010) (310)
Maternal smoking during pregnancy and childhood obesity. (2003) (298)
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain (2011) (297)
The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. (1992) (244)
Nitrative and Oxidative Stress in Toxicology and Disease (2009) (242)
Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain (2009) (233)
Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. (2013) (230)
Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. (2002) (225)
Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice (1994) (207)
Potential neurotoxicity of ketamine in the developing rat brain. (2009) (202)
Childhood obesity is associated with maternal smoking in pregnancy (2002) (195)
Fetal and adolescent nicotine administration: effects on CNS serotonergic systems (2001) (188)
The role of the N-methyl-d-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture (2005) (187)
Maternal Smoking during Pregnancy and Childhood Obesity (2002) (187)
Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data (2005) (186)
Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. (2006) (180)
Methamphetamine‐Induced Dopaminergic Neurotoxicity: Role of Peroxynitrite and Neuroprotective Role of Antioxidants and Peroxynitrite Decomposition Catalysts (2001) (177)
Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain (1995) (174)
Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. (2005) (170)
Dose-dependent transitions in mechanisms of toxicity. (2004) (170)
Dose-dependent transitions in mechanisms of toxicity: case studies. (2004) (169)
Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey. (2011) (161)
Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. (1995) (159)
Routine complete capsular closure during hip arthroscopy. (2013) (147)
In silico drug repositioning: what we need to know. (2013) (147)
Reverse total shoulder arthroplasty for acute proximal humeral fracture: comparison to open reduction-internal fixation and hemiarthroplasty. (2014) (147)
Mechanistic toxicity evaluation of uncoated and PEGylated single-walled carbon nanotubes in neuronal PC12 cells. (2011) (145)
Risk assessment for neurotoxic effects. (1990) (138)
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate (1991) (132)
Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests. (1988) (126)
Manganese-induced reactive oxygen species: comparison between Mn+2 and Mn+3. (1995) (123)
Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. (2012) (123)
MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels (1994) (123)
Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture. (2013) (122)
Peroxynitrite plays a role in methamphetamine‐induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper–zinc superoxide dismutase (2001) (117)
The effects of l-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex (2008) (115)
Handbook of Developmental Neurotoxicology (1998) (114)
Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC) (1987) (112)
Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats (1993) (109)
Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. (1987) (108)
Neurotoxicology : approaches and methods (1995) (105)
Clinical outcomes of proximal row carpectomy versus four-corner arthrodesis for post-traumatic wrist arthropathy: a systematic review (2015) (104)
Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. (1989) (102)
Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). (1988) (102)
Strategies and Experimental Models for Evaluating Anesthetics: Effects on the Developing Nervous System (2008) (95)
Mode of Action: Disruption of Brain Cell Replication, Second Messenger, and Neurotransmitter Systems During Development Leading to Cognitive Dysfunction—Developmental Neurotoxicity of Nicotine (2005) (94)
Evidence of capsular defect following hip arthroscopy (2013) (94)
Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity (1999) (88)
Gene expression profiling in the developing rat brain exposed to ketamine (2010) (85)
Black-Gold: a simple, high-resolution histochemical label for normal and pathological myelin in brain tissue sections (1999) (80)
Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase (2002) (76)
Incorporating children's toxicokinetics into a risk framework. (2004) (73)
Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain (1998) (73)
Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst (1999) (72)
Me thamphe tarnine‐Induced Dopaminergic Toxicity in Mice (1996) (71)
Effects of silver nanoparticles on human and rat embryonic neural stem cells (2015) (69)
Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen (1995) (69)
Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. (1995) (68)
The use of double-loaded suture anchors for labral repair and capsular repair during hip arthroscopy. (2012) (66)
Hypothermia enhances bcl-2 expression and protects against oxidative stress-induced cell death in Chinese hamster ovary cells. (2001) (65)
Potential Adverse Effects of Prolonged Sevoflurane Exposure on Developing Monkey Brain: From Abnormal Lipid Metabolism to Neuronal Damage. (2015) (63)
Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model (2013) (62)
Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. (1989) (62)
Systems biology approaches for toxicology (2007) (60)
Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding. (1992) (60)
Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats. (1991) (59)
Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine. (1988) (58)
Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine. (1994) (58)
Regulatory landscape of dietary supplements and herbal medicines from a global perspective. (2020) (58)
Effect of manganese on the concentration of amino acids in different regions of the rat brain. (1999) (58)
Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. (1993) (58)
Protective effects of 7-nitroindazole on ketamine-induced neurotoxicity in rat forebrain culture. (2008) (57)
Selective alterations of gene expression in mice induced by MPTP (2005) (56)
Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. (1995) (54)
Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices. (1991) (53)
Protective effect of acetyl-L-carnitine on propofol-induced toxicity in embryonic neural stem cells. (2014) (52)
Acute effects of marijuana smoke on complex operant behavior in rhesus monkeys. (1989) (51)
Parenterally administered 3-nitropropionic acid and amphetamine can combine to produce damage to terminals and cell bodies in the striatum (1996) (51)
Regulatory landscape of nanotechnology and nanoplastics from a global perspective (2021) (50)
Multiple behavioral effects of diazepam in rhesus monkeys (1989) (50)
Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents. (1996) (49)
Prevention of Dopaminergic Neurotoxicity by Targeting Nitric Oxide and Peroxynitrite: Implications for the Prevention of Methamphetamine‐induced Neurotoxic Damage (2000) (49)
l-Carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture (2007) (48)
Prediction of organophosphorus acetylcholinesterase inhibition using three-dimensional quantitative structure-activity relationship (3D-QSAR) methods. (2001) (48)
A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V. (2009) (45)
Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population. (2010) (44)
Comparative Effects of Substituted Amphetamines (PMA, MDMA, and METH) on Monoamines in Rat Caudate (2002) (44)
Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles (2014) (43)
In Vivo Monitoring of Sevoflurane-induced Adverse Effects in Neonatal Nonhuman Primates Using Small-animal Positron Emission Tomography (2016) (43)
Domoic acid-induced neuronal degeneration in the primate forebrain revealed by degeneration specific histochemistry (1995) (43)
Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. (2003) (42)
Effect of prolonged ketamine exposure on cardiovascular physiology in pregnant and infant rhesus monkeys (Macaca mulatta). (2007) (42)
Neurobehavioral assessment: a survey of use and value in safety assessment studies. (2003) (40)
Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs (2020) (39)
Chronic exposure toΔ9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors (1991) (39)
Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice. (2001) (39)
Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward (2015) (37)
Flow cytometric analysis of micronuclei in peripheral blood reticulocytes IV: an index of chromosomal damage in the rhesus monkey (Macaca mulatta). (2008) (37)
A dose-response study of ibogaine-induced neuropathology in the rat cerebellum. (2000) (36)
Cholinergic and dopaminergic alterations in the mouse central nervous system following acute trimethyltin exposure. (2009) (36)
Behavioral test methods workshop. (2005) (35)
Application of a systems biology approach to developmental neurotoxicology. (2005) (35)
Gender-Based Differences in Rats after Chronic Dietary Exposure to Genistein (2001) (35)
Biologically-based dose-response model for neurotoxicity risk assessment. (1998) (34)
Neuroimaging: new approaches for neurotoxicology. (2004) (34)
MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH (2011) (34)
Relationship between ketamine-induced developmental neurotoxicity and NMDA receptor-mediated calcium influx in neural stem cell-derived neurons. (2017) (34)
Preclinical Assessment of Ketamine (2013) (33)
Sex-selective hippocampal alterations after adolescent nicotine administration: effects on neurospecific proteins. (2003) (33)
Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate (2011) (32)
Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells. (2005) (32)
Ketamine-Induced Toxicity in Neurons Differentiated from Neural Stem Cells (2015) (32)
Application of proteomics to the study of molecular mechanisms in neurotoxicology. (2003) (32)
Marijuana exposure and pulmonary alterations in primates (1991) (31)
Acute Effects of Dexfenfluramine (d‐FEN) and Methylenedioxymethamphetamine (MDMA) before and after Short‐Course, High‐Dose Treatment (1998) (31)
Complex brain function in monkeys as a baseline for studying the effects of exogenous compounds. (1988) (30)
Thinking, fast and slow: highlights from the 2016 BJA seminar on anaesthetic neurotoxicity and neuroplasticity (2017) (30)
Biologically based, quantitative risk assessment of neurotoxicants. (1996) (30)
The effect of chronic cocaine exposure throughout pregnancy on maternal and infant outcomes in the rhesus monkey. (1997) (29)
Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation (1996) (28)
Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia (2011) (27)
Principles of developmental neurotoxicology. (1994) (26)
Osteochondral Lesions of the Talus (2012) (26)
The use of MRI to assist the section selections for classical pathology assessment of neurotoxicity. (2014) (26)
MicroPET/CT Imaging of [18F]-FEPPA in the Nonhuman Primate: A Potential Biomarker of Pathogenic Processes Associated with Anesthetic-Induced Neurotoxicity (2012) (26)
A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools (2005) (25)
The genetic toxicology of methylphenidate hydrochloride in non-human primates. (2009) (25)
Serial Block Face-Scanning Electron Microscopy of the Developing Rat Brain Exposed to Ketamine Reveals Changes in Mitochondrial Ultrastructure (2015) (25)
An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate. (2000) (25)
Development of a Physiologically Based Model to Describe the Pharmacokinetics of Methylphenidate in Juvenile and Adult Humans and Nonhuman Primates (2014) (24)
Early neurobehavioral and neurochemical alterations in rats prenatally exposed to imipramine. (1986) (24)
Determination of amino acids in different regions of the rat brain. Application to the acute effects of tetrahydrocannabinol (THC) and trimethyltin (TMT). (1988) (23)
The role of maternal diet in the developmental toxicology of ethanol. (1984) (23)
Food and Drug Administration Proposed Guidelines for Neurotoxicological Testing of Food Chemicals. (1996) (23)
Transplacental pharmacokinetics and maternal/fetal plasma concentrations of cocaine in pregnant macaques near term. (1993) (22)
Trimethyltin induced changes of neurotransmitter levels and brain receptor binding in the mouse. (1983) (22)
Intracranial injection of Fluoro-Gold results in the degeneration of local but not retrogradely labeled neurons (1993) (22)
Application of microPET imaging approaches in the study of pediatric anesthetic‐induced neuronal toxicity (2013) (21)
Developmental toxicology of trimethyltin in the rat. (1986) (20)
Low Environmental Temperatures or Pharmacologic Agents That Produce Hypothermia Decrease Methamphetamine Neurotoxicity in Mice (1995) (20)
Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats. (1989) (20)
Genomics in the land of regulatory science. (2015) (18)
Postnatal Growth Considerations for PBPK Modeling (2007) (18)
Windows® based general PBPK/PD modeling software (2008) (18)
Chronic marijuana smoke exposure in the rhesus monkey. I. Plasma cannabinoid and blood carboxyhemoglobin concentrations and clinical chemistry parameters. (1991) (18)
Lipidomics reveals a systemic energy deficient state that precedes neurotoxicity in neonatal monkeys after sevoflurane exposure. (2017) (18)
Pharmacokinetics of cocaine in pregnant and nonpregnant rhesus monkeys. (1993) (18)
Interactive effects of prenatal cocaine and nicotine exposure on maternal toxicity, postnatal development, and behavior in the rat (1995) (18)
Chronic marijuana smoke alters alveolar macrophage morphology and protein expression (1991) (18)
Development of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in discrete areas of the rabbit brain. (1995) (17)
Gestational exposure to cocaine or pharmacologically related compounds: effects on behavior and striatal dopamine receptors. (1998) (17)
Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain. (1989) (17)
Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure. (1993) (17)
Opportunities to integrate new approaches in genetic toxicology: An ILSI‐HESI workshop report (2014) (16)
Modeling for risk assessment of neurotoxic effects. (1994) (16)
Electron microscopy techniques employed to explore mitochondrial defects in the developing rat brain following ketamine treatment (2018) (16)
Role of the Standard Deviation in the Estimation of Benchmark Doses with Continuous Data (2004) (16)
Elevated environmental temperatures can induce hyperthermia during d-fenfluramine exposure and enhance 5-hydroxytryptamine (5-HT) depletion in the brain. (1997) (16)
Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice (1999) (16)
Biomarkers of neurotoxicity: an overview. (1991) (16)
Concepts on Quantitative Risk Assessment of Neurotoxicants (1995) (16)
Proceedings of the Second Annual Conference of the MidSouth Computational Biology and Bioinformatics Society (2005) (16)
Biomarkers of adult and developmental neurotoxicity. (2005) (15)
Emerging technologies for food and drug safety. (2018) (15)
Methamphetamine‐Induced Dopaminergic Neurotoxicity and Production of Peroxynitrite Are Potentiated in Nerve Growth Factor Differentiated Pheochromocytoma 12 Cells (2002) (15)
Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment. (1998) (15)
Postnatal function following prenatal reserpine exposure in rats: neurobehavioral toxicity. (1989) (15)
Childhood Obesity: The Possible Role of Maternal Smoking and Impact on Public Health (2003) (15)
Drugs and the placenta--a workshop report. (2003) (15)
Minimally invasive biomarkers of general anesthetic-induced developmental neurotoxicity. (2017) (14)
Reduced levels of catalase activity potentiate MPP+-induced toxicity: comparison between MN9D cells and CHO cells. (1999) (14)
Cognitive tests: interpretation for neurotoxicity? (Workshop summary). (2000) (14)
Regulatory bioinformatics for food and drug safety. (2016) (14)
The Evaluation of Sevoflurane-induced Apoptotic Neurodegeneration with microPET using [18F]-DFNSH in the Developing Rat Brain (2013) (14)
Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain. (1989) (14)
Clinical Outcomes of the Flexor Carpi Ulnaris Turnover Flap for Posterior Elbow Soft Tissue Defects. (2015) (13)
Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-fenfluramine (d-Fen) exposure does not evoke a glial-cell response in the central nervous system of rats (1999) (13)
The effects of chronic exposure of manganese on antioxidant enzymes in different regions of rat brain (1997) (13)
Workshop on risk assessment in reproductive and developmental toxicology: addressing the assumptions and identifying the research needs. (1989) (13)
Adaptation to Repeated Cocaine Administration in Rats (2002) (13)
The role of metabolism in the testing of developmental toxicants. (1987) (13)
Programming microphysiological systems for children’s health protection (2017) (12)
The effects of perinatal hypoxia on the behavioral, neurochemical, and neurohistological toxicity of the metabolic inhibitor 3-nitropropionic acid (1995) (12)
Of human-on-a-chip and humans: Considerations for creating and using microphysiological systems (2014) (12)
Quantification and correlation of hip capsular volume to demographic and radiographic predictors (2016) (12)
Prenatal Programming and Toxicity II (PPTOX II): role of environmental stressors in the developmental origins of disease. (2011) (12)
Effect of trimethyltin on amino acid concentrations in different regions of the mouse brain. (1991) (12)
Utilization of Neural Stem Cell-Derived Models to Study Anesthesia-Related Toxicity and Preventative Approaches (2013) (11)
Characterization of Biaxial Stretch as an In Vitro Model of Traumatic Brain Injury to the Blood-Brain Barrier (2017) (11)
Chronic marijuana smoke exposure in the rhesus monkey IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in rats (1991) (11)
Advancing global health through regulatory science research: summary of the Global Summit on Regulatory Science Research and Innovation. (2012) (11)
Alteration in Electroencephalogram and Monoamine Concentrations in Rat Brain following Ibogaine Treatment (1998) (11)
Effects of ischemia-hypoxia induced by interruption of uterine blood flow on fetal rat liver and brain enzyme activities and offspring behavior (1996) (11)
Protective Effects of Acetyl L-Carnitine on Inhalation Anesthetic-Induced Neuronal Damage in the Nonhuman Primate (2013) (11)
Methylphenidate and chromosome damage. (2008) (11)
Arthroscopic-Assisted Outside-In Repair of Triangular Fibrocartilage Complex Tears. (2015) (11)
Prenatal reserpine exposure in rats decreases caudate nucleus dopamine receptor binding in female offspring. (1986) (11)
Positron Emission Tomography with [18F]FLT Revealed Sevoflurane-Induced Inhibition of Neural Progenitor Cell Expansion in vivo (2014) (10)
Biomarkers and their impact on precision medicine (2018) (10)
Protective Effects of Xenon on Propofol-Induced Neurotoxicity in Human Neural Stem Cell-Derived Models (2019) (10)
Perinatal infections: HIV and co-infections in the placenta and therapeutic interventions-a workshop report. (2001) (10)
Persistent neurochemical and structural changes in rat brain after oral administration of MDMA (1989) (10)
Evaluation of mutagenic mode of action in Big Blue mice fed methylphenidate for 24 weeks. (2009) (9)
Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases. (2016) (9)
Biogenic amines as biomarkers for neurotoxicity. (1991) (9)
Site-Selective Neurotoxicity (2002) (9)
Isolation and Characterization of Fluoro‐Jade B, a Selective Histochemical Stain for Neuronal Degeneration (2004) (9)
Comparing Morbidities of Bone Graft Harvesting from the Olecranon Process and the Distal Radius (2016) (9)
Risk Assessment Strategies for Neuroprotective Agents (1995) (9)
Sex differences in cytochrome P450 1B1, an estrogen-metabolizing enzyme, in the rhesus monkey telencephalon (2005) (9)
Improving Predictive Modeling in Pediatric Drug Development: Pharmacokinetics, Pharmacodynamics, and Mechanistic Modeling (2005) (9)
Characterization of uniaxial high-speed stretch as an in vitro model of mild traumatic brain injury on the blood-brain barrier (2018) (8)
Alteration of electroencephalogram and monoamine concentrations in rat brain following ibogaine treatment. (1998) (8)
Effects of Manganese on Inositol Polyphosphate Receptors and Nitric Oxide Synthase Activity in Rat Brain (2001) (8)
Of genomics and bioinformatics (2010) (8)
Inhalation Anesthesia-Induced Neuronal Damage and Gene Expression Changes in Developing Rat Brain. (2013) (8)
The disposition of 14C-trimethyltin in the pregnant rat and fetus. (1989) (8)
Improving predictive modeling in pediatric drug development (2005) (8)
The differential JunB responses to inhibition of succinate dehydrogenase in rat hippocampus and liver (2005) (8)
Novel chemical hazard characterisation approaches (2016) (7)
Saline Load Test for Detecting Traumatic Arthrotomy in the Wrist (2019) (7)
Neuroprotective agents : seventh international conference (1997) (6)
Neuroprotective Effects of Carnitine and Its Potential Application to Ameliorate Neurotoxicity. (2021) (6)
Fetomaternal kinetics of 14C-trimethyltin. (1986) (6)
No increase in carcinogen-DNA adducts in the lungs of monkeys exposed chronically to marijuana smoke. (1992) (6)
Emerging technologies and their impact on regulatory science (2021) (6)
Global Summit on Regulatory Science 2013. (2014) (6)
Transplacental pharmacokinetics of cocaine and benzoylecgonine in plasma and hair of rhesus monkeys. (1998) (6)
Regional Societies: Fostering Competitive Research Through Virtual Infrastructures (2004) (6)
MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates. (2016) (6)
2012 Global Summit on Regulatory Science (GSRS-2012)--modernizing toxicology. (2013) (5)
Gestational exposure to phencyclidine (PCP) in rats decreases PCP binding sites in term fetal brain (1988) (5)
Individual differences in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putamen in unlesioned rats (1996) (5)
Potential toxicities of HIV therapeutics in the developing infant. (2000) (5)
Thallium intoxication produces neurochemical alterations in rat brain. (1990) (5)
Comments on "Teratogen update:bendectin". (1985) (5)
Application of Systems Biology in Developmental Neuronal Toxicity (2011) (5)
Lipid profiling as an effective approach for identifying biomarkers/adverse events associated with pediatric anesthesia. (2018) (5)
Neuroprotection: Past Successes and Future Challenges (2006) (5)
Application of Electrophysiological Method to Study Interactions between Ibogaine and Cocaine (2000) (5)
Time course alterations in tremor and muscarinic receptor binding produced by trimethyltin. (1985) (5)
Assessment of Potential Neuronal Toxicity of Inhaled Anesthetics in the Developing Nonhuman Primate (2012) (5)
Pharmacokinetics and plasma distribution profiles of cocaine c in chronically or acutely exposed rhesus monkeys (1991) (4)
Current and Future Approaches to Neurotoxicity Risk Assessment a (1997) (4)
Effects of Xenon-Based Anesthetic Exposure on the Expression Levels of Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) on Human Neural Stem Cell–Derived Neurons (2019) (4)
Repeated measures designs in behavioral toxicology: application to chronic marijuana smoke exposure. (1990) (4)
Acute effects of perinatal hypoxic insult on concentrations of dopamine, serotonin, and metabolites in fetal monkey brain (1994) (4)
Hip Instability and Arthroscopic Techniques for Complete Capsular Closure and Capsular Plication (2012) (3)
Advancing translation of biomarkers into regulatory science. (2015) (3)
Age and Dietary Factors in Hippocampal Sensitivity to Trimethyltin (1992) (3)
Chapter 42 – Quantitative Models of Risk Assessment for Developmental Neurotoxicants (1998) (3)
Biomarkers of Developmental Neurotoxicity (1992) (3)
Author reply: reverse total shoulder for acute proximal humeral fracture: comparison to open reduction-internal fixation and hemiarthroplasty. (2014) (3)
Altered hepatic microsomal function and elevated protooncogene expression as residual effects in rats exposed to delta-9-tetrahydrocannabinol. (1989) (3)
Nonhuman Primate Models and Developmental Neuronal Toxicity (2012) (3)
Prenatal Programming and Toxicity II (PPTOX II): Role of Environmental Stressors in the Developmental Origins of Disease (2011) (3)
Neuroprotection or Neurotoxicity (2003) (3)
Long-lasting cognitive deficits in rhesus monkeys after neonatal general anesthesia induced by isoflurane plus nitrous oxide (2015) (3)
Ketamine and Glutamate Receptors: Potential Toxicity of General Anesthetics during Rapid Brain Development (2008) (3)
Systems Biology Approaches to Neurotoxicity Studies during Development (2010) (3)
Neuroimaging: strategies to illuminate environment-disease linkages. Session II. Summary and research needs. (2004) (3)
Neural Cell Biology (2016) (3)
Improving Risk Assessment: Toxicological Research Needs (2002) (3)
Effects of phencyclidine on nitric oxide synthase activity in different regions of rat brain (1995) (3)
Neurochemical evaluation of rats prenatally exposed to the adrenergic agonists clonidine and lofexidine. (1988) (3)
Anesthetic Drug-Induced Neurotoxicity and Compromised Neural Stem Cell Proliferation (2015) (3)
Concern over decreased training in embryology and developmental/reproductive toxicology. (2004) (3)
Localization of domoic acid induced neural degeneration in the primate forebrain as revealed by conventional silver methodologies and by a novel fluorescent technique (1993) (3)
Neuroprotective agents : clinical and experimental aspects (1995) (3)
MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates. (2021) (3)
A Randomized Controlled Laboratory Study on the Long-Term Effects of Methylphenidate on Cardiovascular Function and Structure in Rhesus Monkeys (2018) (2)
Chronic marijuana (MJ) smoking and urinary cortisol (UC) excretion in the monkey. (1989) (2)
The Developing Nervous System (2010) (2)
Basic Biochemical Approaches in Neurotoxicology (1995) (2)
Effects of chronic delta-9-THC treatment on cardiac beta-adrenoceptors in rats (1987) (2)
Risk assessment of domoic acid with the use of quantitative histological techniques (1998) (2)
Neuroprotective agents : eighth international neuroprotection society meeting (2007) (2)
Meal‐induced increase in plasma gastrin immunoreactivity in the rhesus monkey (Macaca mulatta) (1989) (2)
Total Wrist Fusion Using an Intramedullary Rod Technique With Proximal Row Carpectomy. (2015) (2)
Atraumatic Microinstability and Surgical Technique (2014) (2)
Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-fenfluramine exposure is preventable. (1999) (2)
Lipidomics Reveals Changes in Metabolism, Indicative of Anesthetic-Induced Neurotoxicity in Developing Brains. (2018) (2)
Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research. (2020) (2)
Plasma distribution of delta-9-tetrahydrocannabinol (THC) in the rhesus monkey after marijuana smoke exposure. (1987) (2)
Application of microRNA profiling to understand sevoflurane-induced adverse effects on developing monkey brain. (2020) (2)
Questions and Answers (2003) (2)
Role of Serotonergic Systems in Behavioral Toxicity (1995) (2)
Neurons-Nerve Cells (2017) (1)
Evaluation of hippocampus in rhesus monkeys after chronic (1-year) inhalation exposure to marijuana: II. Morphometric methods (1990) (1)
Corrigendum to “Neuroimaging: New Approaches for Neurotoxicology” [NeuroToxicology 25 (4) (2004) 525–531] (2005) (1)
Neuroprotection or neurotoxicity: impact of discontinuous dose-response curves on risk assessment. (2003) (1)
Disposition of 3H-ddC in the pregnant rhesus monkey (1992) (1)
Alterations in Electroencephalographic Signals and Monoamine Concentrations in the Rat Brain Following Cocaine and Methamphetamine Treatment (1996) (1)
Application of Nonhuman Primate Models in the Studies of Pediatric Anesthesia Neurotoxicity. (2022) (1)
SYMPOSIUM OVERVIEW Biologically Based, Quantitative Risk Assessment of Neurotoxicant s (1996) (1)
A diagnostic system based on a multi-decision approximate rules model (1997) (1)
Neurovascular unit components on a chip as a model to study traumatic brain injury (2016) (1)
Site-selective action (2002) (1)
Atraumatic Instability and Surgical Technique (2021) (1)
Questions and Answers (2003) (1)
Biologically Based Dose‐Response Model for Neurotoxicity Risk Assessment (1995) (1)
Brain receptor binding in the mouse. (1983) (1)
Behavioral, Neurochemical, and Neurohistological Effects of Chronic Marijuana Smoke Exposure in the Nonhuman Primate (2019) (1)
Individual differencs in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putament in unlesioned rats (2008) (1)
Anti-HIV therapy and the placenta workshop (1994) (1)
Teratology Primer-2nd Edition (7/9/2010) (2010) (1)
The Utility of a Nonhuman Primate Model for Assessing Anesthetic-Induced Developmental Neurotoxicity (2017) (1)
The Role of Caspase III Inhibition in Methamphetamine‐Induced Alterations in p53 and bcl‐2 Expression (2003) (1)
Summary of Survey Results from the Third International Conference on Neuroprotective Agents (1997) (1)
Animal/Human Concordance (2018) (1)
Commentary: Maternal smoking during pregnancy: hazard for what? (2007) (0)
Chapter 29 – Neurotoxicology of Pesticides (2010) (0)
The influence of temperature of methamphetamine neurotoxicity (1991) (0)
Preface (2005) (0)
Comparison of the Two Hybrid Rough-Fuzzy Approaches For Classification (1997) (0)
Posterior Elbow Soft-Tissue Reconstruction Using a Flexor Carpi Ulnaris Muscle Turnover Flap: Level 4 Evidence (2014) (0)
Neural stem cell models to studying pediatric anesthetic neurotoxicity (2015) (0)
Preface (1997) (0)
Artificial intelligence and real-world data for drug and food safety - A regulatory science perspective. (2023) (0)
Meeting Report: Behavioral Test Methods Workshop (2005) (0)
Confirmation of the mode of action of anesthetic‐induced developmental neurotoxicity with gene expression studies (2010) (0)
Systems biology/systems toxicology: application to developmental neurotoxicology/neuroprotection. (2005) (0)
Neurotoxic Effects of Anesthetics and Potential Protective Agents (2010) (0)
Thoughts From a Research Career by William Slikker Jr, the ATS 2019 Mildred S. Christian Career Achievement Award Winner (2019) (0)
Characterization of Biaxial Stretch as an In Vitro Model of Traumatic Brain Injury to the Blood-Brain Barrier (2017) (0)
Questions and answers: Session V: Neuroprotective approaches and models (2005) (0)
Antioxidant agent ameliorates anesthetic-induced toxicity in rat embryonic neural stem cells (2015) (0)
Studies on Developmental Exposures to Anesthetic Agents and Stem Cell Derived Models (2015) (0)
Preface (1999) (0)
Effects of Xenon-Based Anesthetic Exposure on the Expression Levels of Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) on Human Neural Stem Cell–Derived Neurons (2019) (0)
Perinatal Rhesus Monkey Models and Anesthetic‐Induced Neuronal Cell Death (2010) (0)
Advancing regulatory science to enhance medical product development and public health (2013) (0)
Analysis of biofluid lipid changes: potential biomarkers for detecting central nervous system diseases and neurotoxicity (2021) (0)
Risk Assessment for Occupational Neurotoxicants (2020) (0)
The effects of chronic methylphenidate treatment on the performance of rhesus monkeys in the NCTR operant test battery (2009) (0)
Evaluation of Dopamine Receptor Integrity after Sevofl urane Exposure in Neonatal Rat Brain Using Positron Emission Tomography (2018) (0)
The effect of dietary fortification on blood ethanol concentrations, caloric consumption, and weight gain during ethanol consumption in mice. (1982) (0)
Preface (2001) (0)
Ketamine-Induced Toxicity in Neurons Differentiated from Neural Stem Cells (2015) (0)
Utilization of Neural Stem Cell-Derived Models to Study Anesthesia-Related Toxicity and Preventative Approaches (2013) (0)
Developmental neuropharmacology/neurotoxicology. (1985) (0)
Identifying Potential Biomarkers, Mechanisms and Protective Strategies for General Anesthetic‐Induced Neurotoxicity in the Developing Nonhuman Primate (2018) (0)
University of Birmingham Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: (2017) (0)
4. Schwann Cells (2016) (0)
What it means to be global. (2012) (0)
Oxidative stress: A neurochemical mechanism of manganese-induced neurotoxicity (1998) (0)
Evaluation of hippocampus in rhesus monkeys after chronic (1-year) inhalation exposure to marijuana: I. Electron microscopy (1990) (0)
Risk Assessment and Neurotoxicology (1999) (0)
Effects of ibogaine on neurohormones and neurotransmitter systems in rat (1996) (0)
Selected Peer-Reviewed Articles from the 10th International Conference on Neuroprotective Agents (ICNA 2010) (2011) (0)
Preface (2003) (0)
A Systems Biology Approach to Assess the Impact of Pesticides on the Nervous SystemaaDisclaimer: The views presented in this overview do not necessarily reflect those of the U.S. FDA. (2010) (0)
Neurochemical and Biomolecular Approaches (1995) (0)
神経毒性のトランスレーショナル・バイオマーカー：同定と検証へのILSI-HESIコンソーシアムの展望 (2014) (0)
Comprar Neuroprotective Agents | BRUCE TREMBLY | 9781573316859 | Blackwell Publishing (2008) (0)
Persistent neurochemical effects of orally administered methylenedioxymethamphetamine mdma in rats and monkeys (1989) (0)
S16-1Preclinical imaging as a translatable biomarker to assess product safety (2016) (0)
LETTER TO EDITOR What It Means to Be Global (2012) (0)
Relationship between anesthetic-induced toxicity and NMDA receptor-mediated calcium influx in developing neurons (2017) (0)
Oligodendrocytes [Myelin-related Glial Cells in the Central Nervous System (CNS)] (2017) (0)
Protective Effects of Xenon on Propofol-Induced Neurotoxicity in Human Neural Stem Cell-Derived Models (2019) (0)
Minimally invasive quantitative assessment of inhalation anesthetic-induced brain cell death using microPET imaging (2011) (0)
L-carnitine attenuates anesthetic-induced increases in a marker of glial activation in the developing monkey brain (2012) (0)
Neural Cell Adhesion Molecules in Normal and Abnormal Neural Development (2018) (0)
The NMDA Receptor System and Developmental Neurotoxicity (2021) (0)
Pathways of neurotoxicity and innovative neuroprotective strategies. Preface. (2013) (0)
Preface (2013) (0)
Poster Session AP2: Cell Death and Survival (2004) (0)
Approaches and Models for Evaluating the Toxic Effects of Anesthetics in the Developing Nervous System (2010) (0)
Neuroprotection (2001) (0)
Foreword (2020) (0)
Type-2 Alkene-Induced Nerve Terminal Damage Represents a Unified Mechanism for Neurodegenerative Diseases (Alzheimer's Disease, Parkinson's Disease, ALS) (2007) (0)
Toxicity Prediction—Regulatory Perspective (2017) (0)
University of Birmingham Translational biomarkers of neurotoxicity (2015) (0)
MicroPET/CT Assessment of Minocycline Effects on Anesthetic-Induced Neuronal Injury in Developing Rats (2017) (0)
Preface (1995) (0)
3. Oligodendrocytes [Myelin-related Glial Cells in the Central Nervous System (CNS)] (2016) (0)
POTENTIAL MODEST PROTECTIVE EFFECT OF MIDAZOLAM ON KETAMINE-INDUCED APOPTOSIS IN RAT FOREBRAIN CULTURE (2006) (0)
Defining Nanotechnology to Foster Neuroscience (2009) (0)
Role of Peroxynitrite in Neurodegeneration and Neuroprotective Role of Antioxidants and Peroxynitrite Decomposition Catalysts (2001) (0)
Discontinuation of methylphenidate after long-term exposure in nonhuman primates. (2023) (0)
Windows basedgeneralPBPK/PDmodelingsoftware (2008) (0)
Preface (2007) (0)
Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity (2021) (0)
Systems Biology/Systems Toxicology (2005) (0)
The development of profiles for children with attention deficit disorder and monkeys: a neural network approach (1998) (0)
Application of Systems Biology in Neurotoxicological Studies During Development (2011) (0)
1. Neurons-Nerve Cells (2016) (0)
Subcommittee on Risk Assessment for Sensitive Populations (2010) (0)
The development of profiles for monkeys and children with attention deficit disorder: a neural network approach (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William Iii Slikker?

William Iii Slikker is affiliated with the following schools: